CDC42SE2 (CDC42 small effector 2) is a protein encoded by the CDC42SE2 gene in humans (Gene ID: 56990) that regulates actin cytoskeleton organization by acting downstream of the Rho GTPase CDC42 . CDC42SE2 antibodies are research tools designed to detect and study this protein in experimental models, enabling insights into its role in cellular processes such as immune synapse formation, phagocytosis, and cell shape modulation . These antibodies are critical for applications including Western blot (WB), immunohistochemistry (IHC), and immunofluorescence (IF) .
CDC42SE2 functions as a non-kinase effector of CDC42, facilitating actin filament assembly and modulating CDC42-driven morphological changes . Key roles include:
Actin cytoskeleton organization: CDC42SE2 promotes F-actin accumulation at immunological synapses in T-cells .
Phagocytosis: Participates in early contractile events during macrophage phagocytosis .
Cell signaling: Alters CDC42-mediated signaling pathways impacting cell polarity and motility .
Novus NBP1-82131: Detects ~25 kDa band in human cell lines (RT-4, U-251MG) .
Abcam ab122492: Validated in A431 cells, showing specific cytoplasmic localization .
Thermo TA808193: Effective in paraffin-embedded tissues with HIER pH 6 retrieval .
Novus NBP1-82131: Stains human skeletal muscle with low expression, consistent with endogenous levels .
Abcam ab122492: Demonstrates punctate staining in permeabilized A431 cells, confirming actin-associated localization .
| Application | Novus NBP1-82131 | Abcam ab122492 |
|---|---|---|
| Western Blot | 0.04–0.4 µg/mL | 1:100–1:500 |
| IHC-Paraffin | 1:50–1:200 | 1:50–1:200 |
Defective immune responses: Studies using CDC42SE2 antibodies highlight its role in T-cell activation and phagocytosis, linking actin dynamics to immune function .
Therapeutic potential: Targeting CDC42SE2 pathways may offer strategies for immune disorders or cytoskeleton-related pathologies .
CDC42SE2 (CDC42 Small Effector Protein 2) plays a pivotal role in the organization of the actin cytoskeleton by acting downstream of CDC42, a small GTPase involved in cell signaling. Specifically, CDC42SE2 induces actin filament assembly, which is essential for various cellular processes such as cell shape changes, migration, and intracellular transport. In activated T-cells, it contributes to F-actin accumulation at the immunological synapse, facilitating effective immune responses . Additionally, CDC42SE2 is implicated in early contractile events during phagocytosis in macrophages .
The CDC42SE2 antibody can be employed in techniques such as immunohistochemistry (IHC), Western blotting (WB), and immunofluorescence (IF) to visualize and quantify CDC42SE2 expression in various cell types. These methods enable researchers to examine how CDC42SE2 influences actin filament assembly and its downstream effects on cellular morphology and motility. For example, using IHC with paraffin-embedded tissues or IF with fixed cells allows for spatial localization of CDC42SE2 within cellular compartments where actin remodeling occurs .
When utilizing CDC42SE2 antibodies in experiments, it is critical to include proper controls to ensure specificity and reliability of results:
Negative Controls: Use tissues or cells known to lack CDC42SE2 expression or treated with non-specific IgG antibodies.
Positive Controls: Include samples with confirmed CDC42SE2 expression, such as human colon tissue or lymphoma tissue validated by IHC .
Isotype Controls: Employ isotype-matched antibodies to rule out non-specific binding.
Blocking Experiments: Pre-incubate the antibody with its immunogen peptide to confirm specificity .
These controls help validate findings and minimize artifacts arising from non-specific binding or technical errors.
The specificity of CDC42SE2 antibodies is typically confirmed through multiple validation techniques:
Protein Arrays: Antibodies are tested against a panel containing the target protein alongside hundreds of non-specific proteins to ensure minimal cross-reactivity .
Epitope Mapping: Advanced methods like peptide scanning and microbial display are used to identify the exact binding site (epitope) on the target protein .
Enhanced Validation: Techniques such as orthogonal RNAseq provide additional layers of validation by correlating antibody binding with gene expression profiles .
These approaches ensure that the antibody selectively binds to CDC42SE2 without cross-reacting with unrelated proteins.
For Western blotting applications, CDC42SE2 antibodies should be used under optimized conditions:
Dilution: Typically, a dilution range of 0.04–0.4 μg/mL is recommended .
Buffer Composition: Use PBS (pH 7.3) supplemented with glycerol and sodium azide for stability .
Detection Method: Enhanced chemiluminescence (ECL) is commonly employed for signal detection .
Sample Preparation: Ensure proper lysis conditions to extract proteins from tissues such as liver or plasma lysates validated for CDC42SE2 expression .
These parameters should be titrated based on experimental requirements to achieve optimal signal-to-noise ratios.
CDC42SE2 plays a significant role in immune synapse formation by mediating F-actin accumulation at contact sites between T-cells and antigen-presenting cells. This actin remodeling facilitates stable interactions required for effective immune signaling and subsequent activation of T-cells . Immunofluorescence studies using CDC42SE2 antibodies can visualize its localization at these synaptic regions, providing insights into its functional dynamics during immune responses .
Researchers may encounter several challenges when interpreting data:
Non-Specific Binding: Despite rigorous validation, some antibodies may exhibit cross-reactivity under certain conditions.
Variable Expression Levels: Tissue-specific expression patterns can complicate comparisons across samples.
Technical Artifacts: Factors such as improper antigen retrieval or suboptimal fixation can lead to inconsistent staining results.
Biological Complexity: The multifunctional nature of CDC42SE2 means its effects may vary depending on cellular context or experimental conditions .
Addressing these challenges requires careful experimental design and thorough validation.
Post-translational modifications (PTMs) such as phosphorylation or acetylation can modulate CDC42SE2 activity. To investigate PTMs:
Use antibodies specific for modified forms of CDC42SE2.
Employ techniques like mass spectrometry coupled with immunoprecipitation to identify PTMs.
Perform functional assays comparing wild-type and mutant forms of CDC42SE2 lacking modification sites .
These approaches help elucidate how PTMs influence the protein's role in actin cytoskeleton dynamics.
Antigen retrieval is crucial for exposing epitopes masked during tissue fixation:
TE Buffer (pH 9.0): Commonly recommended for optimal retrieval of antigens in human colon tissue .
Citrate Buffer (pH 6.0): An alternative method suitable for certain tissue types .
Heat-Induced Epitope Retrieval (HIER): Use microwave or water bath heating protocols tailored to buffer composition.
Selecting appropriate retrieval methods ensures robust staining with minimal background interference.
CDC42SE2 contributes to early contractile events during phagocytosis by regulating actin filament assembly at phagosomal sites. This activity facilitates engulfment and internalization of pathogens or debris by macrophages . Functional studies using knockdown or overexpression systems combined with antibody-based detection can dissect its mechanistic role in phagocytic processes .
Yes, ELISA kits targeting CDC42SE2 enable quantification in biological samples such as plasma or serum:
Sandwich ELISA Format: Employ capture and detection antibodies specific for different epitopes on CDC42SE2.
Sensitivity Range: Detection limits typically span from picograms per milliliter to nanograms per milliliter depending on kit specifications .
Sample Volume: Ensure sufficient sample volume (e.g., 100 μL) for accurate measurements.
ELISA provides a high-throughput method for assessing protein levels across diverse experimental conditions.
To ensure reproducibility:
Use standardized protocols validated across multiple laboratories.
Include detailed documentation of antibody lot numbers and storage conditions.
Perform replicate experiments under identical conditions.
Share raw data and metadata publicly for peer verification.
Reproducibility is critical for advancing scientific understanding and building consensus around findings related to CDC42SE2.